AVNS logo

AVNS

Avanos Medical Inc.

$11.94
+$0.07(+0.59%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$537.34M
Volume
647.28K
52W Range
$9.30 - $25.36
Target Price
$14.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$1.6B$566.2M$611.6M$652.3M$697.6M$714.8M$744.6M$684.1M$673.3M$687.8M
Total Revenue
$1.6B$566.2M$611.6M$652.3M$697.6M$714.8M$744.6M$684.1M$673.3M$687.8M
COST OF GOODS SOLD
Cost of Revenue
$-1.0B$-269.0M$-274.7M$-261.4M$295.4M$341.5M$287.8M$289.9M$293.6M$306.5M
GROSS PROFIT
Gross Profit
$531.6M$297.2M$336.9M$390.9M$402.2M$373.3M$299.2M$394.2M$379.7M$381.3M
OPERATING EXPENSES
Operating Expenses
$435.3M$404.3M$380.0M$390.4M$457.9M$419.4M$355.4M$358.7M$375.5M$340.8M
Research & Development
$32.3M$38.4M$38.2M$41.8M$37.7M$34.9M$32.3M$29.2M$27.2M$26.2M
Research Expense
$32.3M$38.4M$38.2M$41.8M$37.7M$34.9M$32.3M$29.2M$27.2M$26.2M
Selling, General & Administrative
$398.5M$346.2M$321.7M$340.4M$399.1M$332.6M$300.3M$326.5M$335.0M$318.5M
Selling & Marketing Expenses
$398.5M$346.2M$321.7M$340.4M------------
General & Administrative Expenses
$-22.0M$-22.0M$-23.9M$-19.6M$399.1M$332.6M$300.3M$326.5M$335.0M$318.5M
Promotion & Advertising
------$-2.3M------------
Salaries & Wages
$-14.0M$-15.0M$-12.6M$-10.5M$500.0K$700.0K$800.0K------
Depreciation & Amortization
$-65.4M$-65.2M$-18.8M$-13.5M$16.9M$23.5M$21.6M$17.5M$19.2M$20.3M
Depreciation & Amortization
$-65.4M$-65.2M$-18.8M$-13.5M$16.9M$23.5M$21.6M------
Amortization
$-26.0M$-21.0M$-20.7M$-20.0M$800.9M$802.5M$801.6M$760.3M$796.1M$455.6M
Other Operating Expenses
$4.5M$19.7M$20.1M$8.2M$21.1M$51.9M$22.8M$3.0M$13.3M$-3.9M
OPERATING INCOME
Operating income
$96.3M$-107.1M$-43.1M$500.0K$-55.7M$-46.1M$10.4M$35.5M$4.2M$-396.2M
EBITDA
$-312.0M$-41.3M$18.9M$41.8M$-12.1M$-2.0M$-500.0K$84.4M$53.2M$-345.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$33.1M$32.7M$31.6M$26.4M$15.0M$15.6M$3.3M$10.0M$15.0M$12.2M
Intinc
$300.0K$600.0K$2.5M$7.8M$6.7M$1.2M$200.0K$1.2M$2.9M$5.1M
Net Non-Operating Interest Income/Expense
$-32.8M$-32.1M$-29.1M$-18.6M$-8.3M$-14.4M$-3.1M$-8.8M$-12.1M$-7.1M
Other Income/Expense
$-1.6B$-1.6B--$-716.4M$-734.1M$9.6M$1.8M$7.8M--$-6.9M
Other Special Charges
$-1.0M------------------
SPECIAL ITEMS
Restructring And Mn A Income
$-70.4M$-29.1M$-43.2M$-54.7M$29.2M$30.3M$22.6M------
Special Income Charges
$-474.0M$29.1M$43.2M$54.7M$-29.2M$-30.3M$-22.6M--$-28.2M$-436.7M
Impairment of Capital Assets
$474.0M----------------$436.7M
PRE-TAX INCOME
EBIT
$-377.4M$-106.5M$-40.6M$8.3M$-49.0M$-44.9M$-38.8M$36.7M$7.1M$-391.1M
Pre-Tax Income
$-410.5M$-139.2M$-72.2M$-18.1M$-64.0M$-60.5M$7.3M$26.7M$-7.9M$-403.3M
INCOME TAX
Tax Provision
$15.8M$-55.9M$-40.1M$-9.6M$-18.1M$-33.3M$-11.2M$5.2M$2.0M$-17.0M
NET INCOME
Net Income
$-426.3M$-83.3M$-32.1M$-8.5M$-45.9M$-27.2M$6.3M$50.5M$-61.8M$-392.1M
Net Income (Continuing Operations)
$-426.3M$-83.3M$-32.1M$-8.5M$-45.9M$-27.2M$6.3M$21.5M$-9.9M$-386.3M
Net Income (Discontinued Operations)
$-426.3M$-83.3M$-32.1M$-8.5M$-45.9M$-27.2M$6.3M$50.5M$-61.8M$-392.1M
Net Income (Common Stockholders)
$-426.3M$-83.3M$-32.1M$-8.5M$-45.9M$-27.2M$6.3M$50.5M$-61.8M$-392.1M
TOTALS
Total Expenses
$-607.5M$135.3M$105.3M$129.0M$753.3M$760.9M$734.2M$648.6M$669.1M$647.3M
SHARE & EPS DATA
Average Shares Outstanding
$46.6M$46.6M$46.8M$47.2M$47.6M$47.8M$47.3M$46.8M$46.8M$46.0M
Average Shares Outstanding (Diluted)
$46.6M$46.6M$46.8M$47.2M$47.6M$47.8M$47.3M$47.2M$46.8M$46.0M
Shares Outstanding
$46.6M$46.7M$46.9M$47.5M$47.8M$48.0M$47.3M$46.6M$46.2M$46.0M
Basic EPS
$-9.15$0.85$1.69$1.22$-0.96$-0.57$0.11$1.08$-1.32$-8.53
Basic EPS (Continuing Operations)
--$-1.79$-0.69$-0.18$-0.96$-0.57$0.11$1.08$-0.21$-8.4
Diluted EPS
$-9.15$0.85$1.69$1.22$-0.96$-0.57$0.11$1.07$-1.32$-8.53
Diluted EPS (Continuing Operations)
--$-1.79$-0.69$-0.18$-0.96$-0.57$0.11$1.07$-0.21$-8.4
OTHER METRICS
Basic Discontinuous Operations
--$2.64$2.38$1.4--------$-1.11$-0.13
Diluted Discontinuous Operations
--$2.64$2.38$1.4--------$-1.11$-0.13
Gain On Sale Of P P E
------------$6.0M------
Net Income Discontinuous Operations
--$123.1M$111.4M$98.4M------$29.0M$-51.9M$-5.8M
Other Gand A
$-22.0M$-22.0M$-23.9M$-19.6M$399.1M$332.6M$300.3M$326.5M$335.0M$318.5M
Other Impairment Of Capital Assets
----------$9.6M$7.8M------
Rent And Landing Fees
$-22.0M$-22.0M$-23.9M$-19.6M------------
Selling Expense
$398.5M$346.2M$321.7M$340.4M------------
Restruct
$-70.4M$-29.1M$-43.2M$-54.7M$29.2M$30.3M$22.6M------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2AVNS$11.94+0.6%647.28K
3
4
5
6

Get Avanos Medical Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.